论文部分内容阅读
目的:探讨分析应用中西医结合疗法治疗老年肝癌患者的临床疗效。方法:选取2012年1月~2012年6月间我院收治的老年肝癌患者48例作为研究对象,将其随机分为治疗组(24例)和对照组(24例)。应用5—氟尿嘧啶联合抗生素为对照组患者进行治疗,为治疗组患者在进行上述治疗的基础上加用健脾养肝汤进行治疗,观察对比两组患者的临床疗效,并将对比的结果及两组患者的临床资料进行回顾性的分析。结果:治疗组患者治疗的总有效率为87.5%,对照组患者治疗的总有效率为66.7%,治疗组患者的临床疗效明显优于对照组患者,差异显著(P<0.05),具有统计学意义。结论:应用中西医结合疗法治疗老年肝癌的临床疗效显著,值得在临床上推广应用。
Objective: To analyze and analyze the clinical efficacy of combined traditional Chinese and western medicine in the treatment of elderly patients with liver cancer. Methods: Forty-eight elderly patients with hepatocellular carcinoma (HCC) who were treated in our hospital from January 2012 to June 2012 were selected as study subjects and randomly divided into treatment group (24 cases) and control group (24 cases). The patients in the treatment group were treated with Jianpi Yanggan Decoction on the basis of the above treatment, and the clinical efficacy of the two groups of patients was observed and compared. The results of the comparison and two Group of patients with clinical data for retrospective analysis. Results: The total effective rate was 87.5% in the treatment group and 66.7% in the control group. The clinical efficacy of the treatment group was significantly better than that of the control group (P <0.05), with statistical significance significance. Conclusion: The clinical curative effect of treating hepatocellular carcinoma of the elderly with integrated traditional Chinese and western medicine is remarkable. It is worth to be popularized and applied clinically.